Skip to main content

MARSHALL WACE, LLP

Position in KRYS — Krystal Biotech, Inc.

CIK 1318757 LONDON, X0

Position in KRYS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$17,654,363
-$27,648,348 QoQ
Shares Held
68,343
-62.8% QoQ
Ownership
0.231%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in KRYS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in KRYS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $17,654,363 68,343
2025-12-31 $45,302,711 183,754
2025-09-30 $22,765,308 128,960
2025-06-30 $15,448,028 112,382
2025-03-31 $3,105,486 17,224
2024-12-31 $1,618,453 10,331
2024-03-31 $996,408 5,600
2023-12-31 $8,795,978 70,901
2023-09-30 $1,105,248 9,528
2023-03-31 $686,194 8,571
2022-12-31 $966,484 12,200
2021-12-31 $7,590,344 108,511
2021-09-30 $1,339,447 25,655
2021-03-31 $2,298,565 29,836
2020-12-31 $445,620 7,427